相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
Jan Boren et al.
EUROPEAN HEART JOURNAL (2020)
Circulating PCSK9 Level and Risk of Cardiovascular Events and Death in Hemodialysis Patients
Hyeon Seok Hwang et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Heart Disease and Stroke Statistics-2019 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2019)
Nonclassical Monocytes in Health and Disease
Prakash Babu Narasimhan et al.
Annual Review of Immunology (2019)
PCSK9 inhibition and inflammation: A narrative review
Massimiliano Ruscica et al.
ATHEROSCLEROSIS (2019)
Reduced plasma PCSK9 response in patients with bacteraemia is associated with mortality
J. Rannikko et al.
JOURNAL OF INTERNAL MEDICINE (2019)
Reduced Proprotein convertase subtilisin/kexin 9 (PCSK9) function increases lipoteichoic acid clearance and improves outcomes in Gram positive septic shock patients
Alex K. K. Leung et al.
SCIENTIFIC REPORTS (2019)
From Focal Lipid Storage to Systemic Inflammation JACC Review Topic of the Week
Peter Libby et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases
Theodore S. Kapellos et al.
FRONTIERS IN IMMUNOLOGY (2019)
Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy
Ye-Xuan Cao et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Variety matters: Diverse functions of monocyte subtypes in vascular inflammation and atherogenesis
Ann-Kathrin Vlacil et al.
VASCULAR PHARMACOLOGY (2019)
The pro-inflammatory phenotype of the human non-classical monocyte subset is attributed to senescence
Siew-Min Ong et al.
CELL DEATH & DISEASE (2018)
MT4-MMP deficiency increases patrolling monocyte recruitment to early lesions and accelerates atherosclerosis
Cristina Clemente et al.
NATURE COMMUNICATIONS (2018)
PCSK9 monoclonal antibodies reverse the pro-inflammatory profile of monocytes in familial hypercholesterolaemia
Sophie J. Bernelot Moens et al.
EUROPEAN HEART JOURNAL (2017)
Monocyte subsets in myocardial infarction: A review
John Arfvidsson et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Lipid Lowering Therapy and Circulating PCSK9 Concentration
Tsuyoshi Nozue
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2017)
The fate and lifespan of human monocyte subsets in steady state and systemic inflammation
Amit A. Patel et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Patrolling Mechanics of Non-Classical Monocytes in vascular inflammation
Konrad Buscher et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2017)
New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway
Zhi-Han Tang et al.
ATHEROSCLEROSIS (2017)
PCSK9 regulates the chemokine receptor CCR2 on monocytes
Jana Grune et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Local effects of human PCSK9 on the atherosclerotic lesion
Ilaria Giunzioni et al.
JOURNAL OF PATHOLOGY (2016)
Genetic and Pharmacological Inhibition of TREM-1 Limits the Development of Experimental Atherosclerosis
Jeremie Joffre et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Role and analysis of monocyte subsets in cardiovascular disease Joint consensus document of the European Society of Cardiology (ESC) Working Groups Atherosclerosis & Vascular Biology and Thrombosis
Christian Weber et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humans
B. Thaler et al.
SCIENTIFIC REPORTS (2016)
Association of Small Dense LDL Serum Levels and Circulating Monocyte Subsets in Stable Coronary Artery Disease
Konstantin A. Krychtiuk et al.
PLOS ONE (2015)
Association of plasma PCSK9 levels with white blood cell count and its subsets in patients with stable coronary artery disease
Sha Li et al.
ATHEROSCLEROSIS (2014)
Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease
Konstantin A. Krychtiuk et al.
ATHEROSCLEROSIS (2014)
Relation of circulating PCSK9 concentration to fibrinogen in patients with stable coronary artery disease
Yan Zhang et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2014)
Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin
Susan Kuhnast et al.
JOURNAL OF LIPID RESEARCH (2014)
PCSK9 is a critical regulator of the innate immune response and septic shock outcome
Keith R. Walley et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Inflammation and coagulation in atherosclerosis
K. A. Krychtiuk et al.
HAMOSTASEOLOGIE (2013)
Elevated PCSK9 Levels in Untreated Patients With Heterozygous or Homozygous Familial Hypercholesterolemia and the Response to High-Dose Statin Therapy
Frederick Raal et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Statins, Plasma Proprotein Convertase Subtilisin/Kexin Type 9 Concentrations, and LDL Lowering
Amit Khera
CLINICAL CHEMISTRY (2012)
PCSK9 siRNA suppresses the inflammatory response induced by oxLDL through inhibition of NF-κB activation in THP-1-derived macrophages
Zhihan Tang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2012)
CD14++CD16+ Monocytes Independently Predict Cardiovascular Events
Kyrill S. Rogacev et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression
Stephane Potteaux et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Nomenclature of monocytes and dendritic cells in blood
Loems Ziegler-Heitbrock et al.
BLOOD (2010)
A new method for measurement of total plasma PCSK9: clinical applications
Genevieve Dubuc et al.
JOURNAL OF LIPID RESEARCH (2010)
Genetic and Metabolic Determinants of Plasma PCSK9 Levels
Susan G. Lakoski et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Inflammation stimulates the expression of PCSK9
Kenneth R. Feingold et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6Chi and Ly6Clo monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice
Christophe Combadiere et al.
CIRCULATION (2008)
Sterol-dependent regulation of proprotein convertase subtilisin/kexin type 9 expression by sterol-regulatory element binding protein-2
Hyun Jeong Jeong et al.
JOURNAL OF LIPID RESEARCH (2008)
Atorvastatin increases human serum levels of proprotein convertase subtilisin/kexin type 9
Holly E. Careskey et al.
JOURNAL OF LIPID RESEARCH (2008)
Ly-6C(hi) monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata
Filip K. Swirski et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques
Frank Tacke et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Sequence variations in PCSK9, low LDL, and protection against coronary heart disease
JC Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response
C Sunderkötter et al.
JOURNAL OF IMMUNOLOGY (2004)
Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia
G Dubuc et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
M Abifadel et al.
NATURE GENETICS (2003)
分享论文
